Advertisement
Home »

Nemolizumab Offers Significant Itch Reduction in Prurigo Nodularis

Mar 23, 2023

REFERENCES & ADDITIONAL READING

  1. Kwatra S. Nemolizumab monotherapy improves itch, skin lesions, and sleep disturbance in patients with prurigo nodularis: Results from a phase 3 trial (OLYMPIA 2). S025, AAD Annual Meeting 2023, 17-21 March, New Orleans.

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


EXPLORE MORE

Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

RELEVANT ARTICLES FOR YOU

Advertisement